Advertisement

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Improved Turnaround Times | Median time to first decision: 12 days

Research ArticleAdult Brain

Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis

R. Kurokawa, A. Baba, M. Kurokawa, A. Capizzano, O. Hassan, T. Johnson, Y. Ota, J. Kim, A. Hagiwara, T. Moritani and A. Srinivasan
American Journal of Neuroradiology February 2022, 43 (2) 202-206; DOI: https://doi.org/10.3174/ajnr.A7406
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
Please verify that you are a real person

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Advertisement
Print
Download PDF
Email Article
Cite this article
0 Responses
Respond to this article
Bookmark this article
Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis
R. Kurokawa, A. Baba, M. Kurokawa, A. Capizzano, O. Hassan, T. Johnson, Y. Ota, J. Kim, A. Hagiwara, T. Moritani, A. Srinivasan
American Journal of Neuroradiology Feb 2022, 43 (2) 202-206; DOI: 10.3174/ajnr.A7406
del.icio.us logo Twitter logo Facebook logo Mendeley logo
Purchase

Jump to section

Advertisement